The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / On the Edge with Medicare: Will Cuts Drive Rheumatologists to Opt Out?

On the Edge with Medicare: Will Cuts Drive Rheumatologists to Opt Out?

November 1, 2010 • By Sue Pondrom

  • Tweet
  • Email
Print-Friendly Version / Save PDF

When Congress returns for its lame-duck session on November 15, rheumatologists are hoping that legislators will eliminate a proposed 23% cut in Medicare reimbursement to physicians scheduled to go into effect December 1, and revise the Medicare payment methodology to ensure appropriate physician payments in the future. In spite of huge lobbying efforts by physician societies, it’s still not certain what Congress will do. If the cuts go through, however, it could lead to numerous rheumatologists opting out of Medicare.

You Might Also Like
  • Congress Weighs Medicare Cuts Again
  • Rheumatologists React to Looming Medicare Payment Reductions
  • Contact Congress Today about Medicare Reimbursement
Explore This Issue
November 2010
Also By This Author
  • Stop the Rheumatoid Arthritis (RA) Cascade Early

It all goes back to 1997 when the Sustainable Growth Rate (SGR) was established by Congress as a target rate of growth in Medicare Part B spending for physician services. If spending exceeds SGR targets – which it has since 2002 – then physician payment is supposed to be cut.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Linked to performance of the overall economy, the SGR target was set with 1996 spending as the base year with each year’s payment determined by comparing cumulative actual expenditures to cumulative target expenditures in the prior year. In early years, volume growth was below per-capita GDP, so payments were at or above the Medicare Economic Index. Since 2002, volume growth has increased and GDP slowed, with SGR calling for rate cuts that by 2010 total 21%. However, since 2003 Congress has repeatedly passed temporary fixes to prevent severe cuts.

“We get more and more in debt with this formula,” says Susan Hoch, MD, a rheumatologist at the University of Pennsylvania in Philadelphia who has been active in ACR advocacy. “It’s not clear that this formula is even a viable mechanism. The problem is it gets hung up in politics and no one has the political will to set a target on what we spend on physician services. To reform the SGR completely, you need bipartisanship, which isn’t likely on the horizon.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

And 2010 was a particularly rocky year. Medicare payments at the 2009 level were extended through May in various legislative efforts. Then, in late June, a new law rescinded the 21% payment cut and provided a 2.2% increase in Medicare payments through November 30, 2010.

This brings us to the lame-duck Congress that must address this issue. If the 21% cut is applied and the 2.2% increase eliminated, rheumatologists will see a little more than 23% cut in reimbursement. Meanwhile, the ACR, AMA, and others have urged Congress, at a minimum, to pass a 13-month extension prior to November 30, 2010.

What If?

If the payment cuts go through, rheumatologists who currently accept Medicare assignment have three contractual options:

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
  • Remain a Medicare participating physician at the lower payment rates.
  • Choose to be a nonparticipating physician, seeing Medicare patients on a case-by-case basis. These physicians agree to accept 5% less than participating physicians, but they can bill patients for up to 15% more (a limiting charge) than the Medicare allowance.
  • Opt out and become a private contracting physician, billing patients directly. (Read “Opting Out of Medicare“ for guidelines on the opt-out process.)

Already, rheumatologists and other specialists have grappled with the loss of consultation fees since January 1, 2010. How will they react now if the payment cuts go through?

Pages: 1 2 3 | Single Page

Filed Under: Billing/Coding, Legislation & Advocacy, Practice Management, Professional Topics Tagged With: Billing, Centers for Medicare and Medicaid Services, CMS, cost, Cuts, Medicare, Reimbursement, SGR, Sustainable Growth RateIssue: November 2010

You Might Also Like:
  • Congress Weighs Medicare Cuts Again
  • Rheumatologists React to Looming Medicare Payment Reductions
  • Contact Congress Today about Medicare Reimbursement
  • Sequester Affects Rheumatologists on Two Fronts—Medicare Reimbursement and Research Funding

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)